Answer
No, the MSN Laboratories Europe Ltd olmesartan medoxomil/hydrochlorothiazide 40 mg/12.5 mg and 40 mg/25 mg film-coated tablet products should not be used in moderate or severe hepatic impairment, cholestasis or biliary obstruction.
Sources for this answer
- Olmesartan medoxomil/hydrochlorothiazide 40 mg/12.5 mg and 40 mg/25 mg mg film-coated tabletsMSN Laboratories Europe Ltd · emc · SmPC §4.2 Posology and method of administration · Version 1Document updated
Sources checked